What Is Physiologic Activity on a PET Scan?

Physiologic activity on a PET scan refers to the normal, expected uptake of the radioactive tracer by healthy tissues going about their everyday metabolic business. When your scan report mentions “physiologic activity,” it is telling you that the signal in that area comes from ordinary body function, not from cancer or another disease. Because the most common PET tracer is a glucose look-alike, any tissue that naturally burns a lot of glucose will glow on the image, and distinguishing that normal glow from something worrisome is one of the core skills of reading these scans.

Why Normal Tissue Lights Up

The tracer used in most PET scans is a modified sugar molecule called FDG. Your body treats it almost like regular glucose: cells pull it inside through the same doorways they use for sugar, and an enzyme locks it in place. But unlike real glucose, FDG gets stuck partway through the metabolic process and can’t be broken down further. That trapping is what makes the molecule visible on the scanner. Wherever cells are hungry for fuel, FDG accumulates and produces a signal.¹ Cancer cells tend to be ravenous for glucose, which is why PET scans are so useful in oncology. But plenty of normal tissues are metabolically active too, and they take up FDG for perfectly healthy reasons.

The Organs That Routinely Show Up

Radiologists who interpret PET scans carry a mental map of which organs are expected to light up. Normal physiologic uptake is regularly seen in the brain, heart, liver, spleen, gastrointestinal tract, urinary collecting system, bone marrow, and muscles, among other sites.² Some of these are easy to understand: the brain consumes a huge share of the body’s glucose around the clock, so it almost always shows strong, uniform FDG uptake.³ The liver acts as a metabolic workhorse and shows steady, moderate uptake that is so reliable it is often used as the internal reference point against which other organs are compared.⁴

The urinary tract is another guaranteed bright spot. After FDG is filtered through the kidneys, it is not reabsorbed the way real glucose is. Instead, it passes into the urine and collects in the ureters and bladder, producing high activity along the entire urinary collecting system.⁵ This is one reason bladder cancer can be tricky to evaluate with a standard FDG PET: the tumor signal hides behind a pool of hot urine.

The gastrointestinal tract is less predictable. Some people show diffuse, mild uptake throughout the bowel, while others show almost none. This variability is normal but can create confusion when a radiologist is searching for a GI tumor or looking for cancer spread to the abdomen.⁶

The Heart Is Especially Unpredictable

Heart muscle deserves its own discussion because its FDG uptake is notoriously variable. The heart can burn either glucose or fatty acids for fuel, and which one it prefers at the moment of the scan depends on factors like fasting state, insulin levels, and what you ate the day before. Even in people without heart disease who have fasted, the pattern of FDG uptake across different regions of the heart muscle changes substantially from one scan to the next. One study found that regional FDG distribution within the heart varied by roughly 18% in each patient across repeated scans, even though the overall average stayed stable.⁷

This matters clinically when PET scans are used to look for inflammation in the heart, such as in cardiac sarcoidosis. Certain medications further complicate the picture. Corticosteroid therapy, for instance, has been shown to increase the frequency of physiologic heart uptake from about 2.5% to 15% of scans, likely because corticosteroids shift the heart’s fuel preference toward glucose by lowering free fatty acid levels in the blood.⁸ That means a patient being treated with steroids may show heart uptake that looks like active disease but is actually just a metabolic side effect of the medication.

Brown Fat and the Cold-Weather Surprise

One of the most visually striking examples of physiologic activity involves brown adipose tissue, commonly called brown fat. Unlike ordinary white fat, brown fat burns calories to generate heat, and when it is activated, it devours glucose at a rate high enough to produce dramatic FDG uptake. On a PET image, activated brown fat creates a characteristic symmetric pattern, most often between the neck muscles and above the collarbones, under the clavicles, and in the armpits.⁹

Brown fat uptake is more common in lean people, in women, in younger patients, and when the scan takes place during cold weather or in a chilly room. Imaging centers try to minimize this by keeping patients warm before injection, sometimes even offering blankets or a heated waiting room. When brown fat does appear, it can temporarily obscure nearby lymph nodes, which is a real diagnostic headache in patients being evaluated for lymphoma or head and neck cancers. The paired CT scan that accompanies most modern PET studies helps, because the bright signal can be matched to fat tissue on the CT rather than to a lymph node.

Muscles Remember What You Did Before the Scan

Skeletal muscles that have been working take up FDG in proportion to how active they were in the hours before the scan. Imaging centers instruct you to rest quietly and avoid exercise beforehand for exactly this reason. Yet even small, unconscious movements can leave a mark. Studies documenting muscle uptake patterns have identified tracer accumulation from chewing gum (lighting up the jaw muscles), talking during the uptake period (vocal cord muscles), reading a book or scrolling a phone (forearm and hand muscles), labored breathing (chest wall), and nervous foot tapping (lower leg muscles).¹⁰ Neck strain from lying flat on the scanner stretcher is another common culprit.

Older adults may show higher muscle glucose uptake than younger people during certain types of physical effort, reflecting age-related differences in how muscles recruit fibers and burn fuel.¹¹ The practical takeaway is that if you exercised the morning of your scan or were anxious and clenching muscles in the waiting room, those muscles may show uptake that has nothing to do with disease.

Hormones, Menstrual Cycles, and Breast Tissue

In premenopausal women, the reproductive organs add another layer of normal variation. The uterine lining shows two peaks of FDG uptake during the menstrual cycle: one during menstruation and another around ovulation. The ovaries also take up FDG around mid-cycle, sometimes enough to mimic an ovarian malignancy on the scan.¹² Radiologists interpreting scans in premenopausal women often need to know where the patient is in her cycle to avoid raising a false alarm about ovarian or uterine pathology.

Breast tissue follows a similar pattern. In premenopausal women with dense breasts, normal background FDG uptake is measurably higher during the periovulatory and luteal phases than during menstruation and the early follicular phase.¹³ Higher background uptake can make small breast lesions harder to spot, which is one reason some researchers have suggested scheduling breast PET imaging during the first half of the cycle when background activity is lower.

Why Children’s Scans Look Different

Pediatric PET scans have their own set of physiologic patterns that would look alarming on an adult. The thymus, a small immune organ behind the breastbone, is large and metabolically active in children and young adults. It normally takes up FDG and can be mistaken for a mass in the chest, especially in patients being treated for lymphoma.¹⁴ After chemotherapy, the thymus often rebounds and becomes even more FDG-avid than it was at baseline. The same rebound phenomenon occurs with tonsils and adenoids: their uptake drops during treatment and then surges during follow-up, peaking between six and twelve months after therapy ends.¹⁵ This “rebound uptake” is a sign of immune recovery, not relapse, but it can be intensely worrying if the interpreting physician isn’t expecting it.

Children’s growing bones also light up in ways adult bones do not. The growth plates at the ends of long bones are metabolically active zones where cartilage is turning into bone, and they produce physiologic FDG uptake that has no adult equivalent.¹⁶ Once growth plates close in late adolescence, this signal disappears.

Medications That Change the Baseline

Beyond the corticosteroid effect on heart uptake discussed earlier, other common medications can alter what “normal” looks like on a PET scan. Metformin, one of the most widely prescribed diabetes drugs, frequently causes intense, diffuse FDG uptake throughout the bowel.¹⁷ The mechanism likely involves metformin’s effect on glucose transporters in the intestinal lining. The bowel uptake it causes can be so bright that it obscures nearby structures, making it harder to evaluate the abdomen for tumor recurrence. Many imaging centers ask patients to stop metformin for a day or two before a PET scan, though this decision is weighed against the risks of disrupting blood sugar control.

Granulocyte colony-stimulating factor (G-CSF), a drug used to boost white blood cell counts after chemotherapy, stimulates the bone marrow and can cause diffuse, intense marrow uptake across the skeleton. Patients who have recently received G-CSF often show a skeleton that glows uniformly, which is physiologic but can mask individual bone metastases hiding within the bright background.

When Normal Activity Gets Mistaken for Disease

The overlap between physiologic uptake and pathologic uptake is the central interpretive challenge of PET imaging. Knowing what normal looks like is the first defense, and PET-CT fusion, which overlays the metabolic PET data onto the anatomical CT image, has dramatically improved the ability to tell the two apart.¹⁸ If a hot spot lines up with a known normal structure on CT, such as a loop of bowel or the collecting system of a kidney, confidence in calling it physiologic goes up considerably.

The problem sharpens when non-cancerous but genuinely abnormal processes also take up FDG. Infections from bacteria, fungi, or mycobacteria produce bright uptake because the immune cells fighting the infection burn glucose at high rates. Sarcoidosis, an inflammatory condition, does the same. Post-surgical inflammation and radiation-treated tissue can also light up.¹⁹ The false-positive rate of PET/CT in the chest has been reported at roughly 13%, attributed largely to inflammatory cells at infection or inflammation sites.²⁰ These aren’t physiologic in the strict sense, since they reflect a disease process, but they share the feature of not being cancer, and they compete for the radiologist’s attention in the same way normal uptake does.

Not All PET Scans Use FDG

Everything discussed so far applies to FDG, the glucose-based tracer used in the vast majority of PET scans. But other radiotracers exist, and each has its own map of normal physiologic uptake that interpreters need to know. PSMA-targeted tracers, increasingly used for prostate cancer imaging, show strong physiologic uptake in the salivary glands, lacrimal (tear) glands, kidneys, and liver.²¹ That salivary gland uptake becomes clinically significant during PSMA-targeted radionuclide therapy, because the tracer delivers radiation to those glands as a side effect, sometimes causing dry mouth.

DOTATATE PET, used for neuroendocrine tumors, has its own set of normal hot spots: the pituitary gland, adrenal glands, spleen, and liver all show expected uptake. The liver’s consistent signal in DOTATATE scans, much like in FDG scans, makes it a useful internal benchmark for distinguishing background from tumor.⁴ Each tracer, in effect, creates a different physiologic landscape, and radiologists who specialize in nuclear medicine learn these maps the way a driver learns alternate routes through a familiar city.

What Your Report Is Really Saying

When your PET scan report says something like “physiologic uptake in the brain, heart, liver, and urinary bladder” or “normal physiologic activity in the gastrointestinal tract,” it is essentially clearing those areas from suspicion. The radiologist is documenting that the signal in those regions matches the expected metabolic behavior of healthy tissue and does not need further investigation. If the report describes uptake in a specific location as “likely physiologic” rather than simply “physiologic,” that subtle language difference usually means the pattern is consistent with normal activity but the radiologist wants your ordering physician to consider the clinical context, such as symptoms or prior imaging, before fully dismissing it.

Patient preparation matters more than most people realize in shaping how clean a scan looks. Fasting for several hours before the scan lowers insulin levels and pushes the heart and muscles toward burning fat instead of glucose, reducing their FDG uptake and making any cancer signal stand out more clearly. Staying still and warm in the waiting room limits muscle uptake and brown fat activation. Holding off on certain medications when your doctor advises it reduces bowel or marrow noise. None of these steps eliminate physiologic activity entirely, because your organs will always need fuel. The goal is to turn the volume down on healthy tissue so that anything abnormal can be heard more clearly above the baseline hum of a living body.